Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease
Under an Elsevier user license
open archive
Keywords
Suvorexant
MK-4305
Orexin
Respiration
Chronic obstructive pulmonary disease
Randomized trial
Cited by (0)
- 1
Current affiliation is Amgen.
- 2
Current affiliation is Takeda.
- 3
Current affiliation is Medivation, Inc.
Copyright © 2015 Elsevier Ltd. All rights reserved.